We are live on ! Find out more
GC

Gould Capital Portfolio holdings

AUM $165M
1-Year Est. Return 19.29%
This Fund
S&P 500
This Quarter Est. Return
-3.37%
1 Year Est. Return
+19.29%
3 Year Est. Return
+52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$124M
AUM Growth
-$6.98M
Cap. Flow
-$1.2M
Cap. Flow %
-0.97%
Top 10 Hldgs %
48.43%
Holding
196
New
3
Increased
30
Reduced
44
Closed
1

Top Buys

Rank Stock Value
1
ALGM icon
Allegro MicroSystems
ALGM
+$1.03M
2
LULU icon
lululemon athletica
LULU
+$990K
3
XYZ
Block Inc
XYZ
+$299K
4
USB icon
US Bancorp
USB
+$297K
5
JNPR
Juniper Networks
JNPR
+$142K

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$1.02M
2
CSGP icon
CoStar Group
CSGP
+$921K
3
META icon
Meta Platforms (Facebook)
META
+$678K
4
RDFN
Redfin
RDFN
+$242K
5
AAPL icon
Apple
AAPL
+$168K

Sector Composition

Rank Sector Weight
1 Technology 16.27%
2 Financials 9.8%
3 Communication Services 6.7%
4 Industrials 5.54%
5 Consumer Discretionary 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SFL icon
176
SFL Corp
SFL
$1.64B
$2.17K ﹤0.01%
200
– –
SONY icon
177
Sony
SONY
$133B
$2.04K ﹤0.01%
125
– –
CHD icon
178
Church & Dwight Co
CHD
$23.7B
$1.83K ﹤0.01%
20
– –
FSR
179
DELISTED
Fisker Inc.
FSR
$1.66K ﹤0.01%
250
– –
LILM
180
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$1.39K ﹤0.01%
2,000
– –
EQC
181
DELISTED
Equity Commonwealth
EQC
$1.37K ﹤0.01%
75
– –
VIV icon
182
Telefônica Brasil
VIV
$20.3B
$1.29K ﹤0.01%
150
– –
PLUG icon
183
Plug Power
PLUG
$2.85B
$1.23K ﹤0.01%
180
– –
TAK icon
184
Takeda Pharmaceutical
TAK
$53.8B
$1.07K ﹤0.01%
70
– –
UPST icon
185
Upstart Holdings
UPST
$2.83B
$1.05K ﹤0.01%
38
– –
SOXX icon
186
iShares Semiconductor ETF
SOXX
$45.2B
$952 ﹤0.01%
6
– –
GE icon
187
GE Aerospace
GE
$378B
$653 ﹤0.01%
8
– –
SHEL icon
188
Shell
SHEL
$252B
$634 ﹤0.01%
10
– –
ADEA icon
189
Adeia
ADEA
$3.04B
$537 ﹤0.01%
50
– –
BPT
190
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$479 ﹤0.01%
70
– –
MVIS icon
191
Microvision
MVIS
$92.5M
$420 ﹤0.01%
13
– –
EBS icon
192
Emergent Biosolutions
EBS
$377M
$316 ﹤0.01%
100
– –
PRGO icon
193
Perrigo
PRGO
$1.46B
$220 ﹤0.01%
7
– –
JWN
194
DELISTED
Nordstrom
JWN
$151 ﹤0.01%
10
– –
GEHC icon
195
GE HealthCare
GEHC
$31.3B
$136 ﹤0.01%
2
– –
BSX icon
196
Boston Scientific
BSX
$71.9B
– –
-18,862
Closed -$1.02M
4 5 6 7
8

Similar funds

OO
Obsido Oy Tampere $165M AUM 17.18% 1-Year Est. Return
GAAM
Grand Alliance Asset Management Central, Hong Kong $165M AUM 359.07% 1-Year Est. Return
TLM
Twin Lions Management Stamford, Connecticut $165M AUM 10.42% 1-Year Est. Return
SHC
SALT Holding Corp Wilmington, Delaware $165M AUM 37.3% 1-Year Est. Return
LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
COA
Charter Oak Advisors New York City, New York $165M AUM 86.5% 1-Year Est. Return
E3F
Eight 31 Financial Midland, Texas $166M AUM 8.23% 1-Year Est. Return
MCM
Moon Capital Management New York $166M AUM 54.85% 1-Year Est. Return

Gould Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Gould Capital held 196 positions worth $124M, down 5.3% from $131M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 2%. Gould Capital opened 3 new positions and exited 1, leaving the 196-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Communication Services.

  • Gould Capital's largest Q3 2023 buy was Allegro MicroSystems: 25,470 shares worth $812K.
  • Gould Capital added most to Block Inc in Q3 2023, an estimated $299K increase.
  • Gould Capital's biggest Q3 2023 reduction was CoStar Group, cutting an estimated $921K.
  • Gould Capital fully exited Boston Scientific in Q3 2023, selling an estimated $1.02M.
  • Gould Capital's ten largest holdings make up 48% of its $124M portfolio in Q3 2023.
  • Gould Capital opened 3 new positions and closed 1 in Q3 2023.
  • Gould Capital's portfolio value fell 5.3% quarter-over-quarter to $124M.

Based on Gould Capital's 13F filing for Q3 2023, filed 9 Nov 2023.